[go: up one dir, main page]

GB202003812D0 - Compositions and methods relating to the treatment of diseases - Google Patents

Compositions and methods relating to the treatment of diseases

Info

Publication number
GB202003812D0
GB202003812D0 GBGB2003812.1A GB202003812A GB202003812D0 GB 202003812 D0 GB202003812 D0 GB 202003812D0 GB 202003812 A GB202003812 A GB 202003812A GB 202003812 D0 GB202003812 D0 GB 202003812D0
Authority
GB
United Kingdom
Prior art keywords
diseases
compositions
treatment
methods relating
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2003812.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILC Therapeutics Ltd
Original Assignee
ILC Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILC Therapeutics Ltd filed Critical ILC Therapeutics Ltd
Priority to GBGB2003812.1A priority Critical patent/GB202003812D0/en
Publication of GB202003812D0 publication Critical patent/GB202003812D0/en
Priority to EP21711947.8A priority patent/EP4121092B1/en
Priority to HUE21711947A priority patent/HUE067223T2/en
Priority to CN202180021884.7A priority patent/CN115697377A/en
Priority to JP2022552669A priority patent/JP2023517525A/en
Priority to PCT/GB2021/050649 priority patent/WO2021186162A1/en
Priority to CA3170629A priority patent/CA3170629C/en
Priority to PL21711947.8T priority patent/PL4121092T3/en
Priority to AU2021238925A priority patent/AU2021238925A1/en
Priority to HRP20240949TT priority patent/HRP20240949T1/en
Priority to US17/906,569 priority patent/US20230203120A1/en
Priority to ES21711947T priority patent/ES2982915T3/en
Priority to KR1020227034755A priority patent/KR20230020943A/en
Ceased legal-status Critical Current

Links

GBGB2003812.1A 2020-03-16 2020-03-16 Compositions and methods relating to the treatment of diseases Ceased GB202003812D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB2003812.1A GB202003812D0 (en) 2020-03-16 2020-03-16 Compositions and methods relating to the treatment of diseases
KR1020227034755A KR20230020943A (en) 2020-03-16 2021-03-16 Hybrid interferons for the treatment of viral infections
CA3170629A CA3170629C (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
HUE21711947A HUE067223T2 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
CN202180021884.7A CN115697377A (en) 2020-03-16 2021-03-16 Compositions and methods relating to the treatment of disease
JP2022552669A JP2023517525A (en) 2020-03-16 2021-03-16 Hybrid interferon for treating viral infections
PCT/GB2021/050649 WO2021186162A1 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
EP21711947.8A EP4121092B1 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
PL21711947.8T PL4121092T3 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
AU2021238925A AU2021238925A1 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
HRP20240949TT HRP20240949T1 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
US17/906,569 US20230203120A1 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections
ES21711947T ES2982915T3 (en) 2020-03-16 2021-03-16 Hybrid interferons for treating viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2003812.1A GB202003812D0 (en) 2020-03-16 2020-03-16 Compositions and methods relating to the treatment of diseases

Publications (1)

Publication Number Publication Date
GB202003812D0 true GB202003812D0 (en) 2020-04-29

Family

ID=70295565

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2003812.1A Ceased GB202003812D0 (en) 2020-03-16 2020-03-16 Compositions and methods relating to the treatment of diseases

Country Status (1)

Country Link
GB (1) GB202003812D0 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037717A1 (en) 2012-09-05 2014-03-13 Alfactye Ltd Compositions and methods relating to the treatment of diseases
WO2015136287A2 (en) 2014-03-12 2015-09-17 Alfacyte Ltd Compositions and methods relating to the treatment of diseases
WO2017046583A1 (en) 2015-09-15 2017-03-23 Alfacyte Ltd Compositions and methods relating to the treatment of diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037717A1 (en) 2012-09-05 2014-03-13 Alfactye Ltd Compositions and methods relating to the treatment of diseases
WO2015136287A2 (en) 2014-03-12 2015-09-17 Alfacyte Ltd Compositions and methods relating to the treatment of diseases
WO2017046583A1 (en) 2015-09-15 2017-03-23 Alfacyte Ltd Compositions and methods relating to the treatment of diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", 1980

Similar Documents

Publication Publication Date Title
IL291140A (en) Compositions and methods for treatment of inflammatory and immune diseases
PL3349783T3 (en) Compositions and methods relating to the treatment of diseases
SG11202112078TA (en) Compositions and methods for the treatment of atpase-mediated diseases
IL287802A (en) Compositions and methods for treatment of ocular diseases
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
IL308221A (en) Compositions and methods for the treatment of depression
GB202017244D0 (en) Methods to extend health-span and treat age-related diseases
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4284383A4 (en) Methods of probiotic treatment to improve human health
IL309317A (en) Treatment of mtres1 related diseases and disorders
CA3266235A1 (en) Compositions and methods for the treatment of skin diseases
EP3979899A4 (en) Compositions and methods for monitoring progression and regression of disease in patients in response to therapy
EP4138852A4 (en) Compositions and methods for the treatment of pain
HUE067796T2 (en) Compositions and methods relating to the treatment of diseases
PL4117709T3 (en) Compositions and methods relating to the treatment of diseases
GB202011945D0 (en) Compositions and methods relating to the treatment of diseases
GB202003812D0 (en) Compositions and methods relating to the treatment of diseases
IL269308A (en) Methods of treatment of hla-b27 related inflammatory diseases and compositions related to same
IL311266A (en) Compositions and methods for the treatment or prevention of autoimmune diseases
GB202012967D0 (en) Compostions and methods relating to the treatment of diseases
EP4267163A4 (en) COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
HK40040367A (en) Compositions and methods relating to the treatment of diseases
GB201903608D0 (en) Compositions and methods relating to the treatment of psoriasis
PL4106783T3 (en) Composition for the treatment of skin and mucous membrane diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)